Sarcopenia in Patients with Chronic Kidney Disease
Yıl: 2022 Cilt: 31 Sayı: 1 Sayfa Aralığı: 3 - 6 Metin Dili: İngilizce DOI: 10.5152/turkjnephrol.2022.21223 İndeks Tarihi: 07-07-2022
Sarcopenia in Patients with Chronic Kidney Disease
Öz: Sarcopenia is defined as a decrease in muscle mass and muscle strength, and its frequency increases with aging. Since
different criteria and methods can be used for its definition, its incidence rates vary. Chronic kidney disease is a progressive process and many systems may be affected in these patients. Studies also show that chronic kidney disease can lead
to the development of sarcopenia. Many factors are held responsible for the development of sarcopenia in chronic kidney
disease. Age, inflammation, malnutrition, uremic toxins, and hormonal imbalance are the most important ones. In this
review, general information about sarcopenia and the development of sarcopenia in patients with chronic kidney disease
are discussed in light of the literature.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- 1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(suppl 5):990S-991S. [CrossRef].
- 2. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the extended group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31.
- 3. Castillo-Olea C, Soto BG-Z, Lozano CC, Zuñiga C. Automatic classification of sarcopenia level in older adults: a case study at Tijuana General Hospital. IJERPH. 2019;16(18):3275. [CrossRef]
- 4. Kim H, Hirano H, Edahiro A, et al. Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int. 2016;16(suppl 1):110-122. [CrossRef]
- 5. Ábrigo J, Elorza AA, Riedel CA, et al. Role of oxidative stress as key regulator of muscle wasting during cachexia. Oxid Med Cell Longev. 2018;2018:2063179. [CrossRef]
- 6. Dalle S, Rossmeislova L, Koppo KK. The role of inflammation in age-related sarcopenia. Front Physiol. 2017;8:1045. [CrossRef]
- 7. Bachettini NP, Bielemann RM, Barbosa-Silva TG, Menezes AMB, Tomasi E, Gonzalez MC. Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European working group on sarcopenia in older people. Eur J Clin Nutr. 2020;74(4):573-580. [CrossRef]
- 8. Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol. 2021;34(4):1347-1372. [CrossRef]
- 9. Souza VA, Oliveira D, Barbosa SR, et al. Sarcopenia in patients with chronic kidney disease not yet on dialysis: analysis of the prevalence and associated factors. PLoS One. 2017;12(4):e0176230. [CrossRef]
- 10. Bataille S, Chauveau P, Fouque D, Aparicio M, Koppe L. Myostatin and muscle atrophy during chronic kidney disease. Nephrol Dial Transplant. 2021;36(11):1986-1993. [CrossRef]
- 11. Pereira RA, Cordeiro AC, Avesani CM, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant. 2015;30(10):1718- 1725. [CrossRef]
- 12. Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33(1):64-68. [CrossRef]
- 13. Roshanravan B, Gamboa J, Wilund K. Exercise and CKD: Skeletal Muscle Dysfunction and Practical Application of Exercise to Prevent and Treat Physical Impairments in CKD. Am J Kidney Dis. 2017 Jun;69(6):837-852.
- 14. Chang YT, Wu HL, Guo HR, et al. Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases. Nephrol Dial Transplant. 2011;26(11):3588-3595. [CrossRef]
- 15. Kim JK, Kim SG, Oh JE, et al. Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis. Korean J Intern Med. 2019;34(3):599-607. [CrossRef]
- 16. Giglio J, Kamimura MA, Lamarca F, Rodrigues J, Santin F, Avesani CM. Association of sarcopenia With nutritional parameters, quality of life, hospitalization, and mortality rates of elderly patients on hemodialysis. J Ren Nutr. 2018;28(3):197-207. [CrossRef]
- 17. As'habi A, Najafi I, Tabibi H, Hedayati M. Prevalence of sarcopenia and dynapenia and their determinants in Iranian peritoneal dialysis patients. Iran J Kidney Dis. 2018;12(1):53-60.
- 18. Wu CH, Chao CT, Liang PC, Shih TTF, Huang JW. Computed tomography-based sarcopenia in patients receiving peritoneal dialysis: correlation with lean soft tissue and survival. J Formos Med Assoc. 2021:S0929-6646(21)00306-5. [CrossRef]
- 19. Ozkayar N, Altun B, Halil M, et al. Evaluation of sarcopenia in renal transplant recipients. Nephrourol Mon. 2014;6(4):e20055. [CrossRef]
- 20. Yanishi M, Kimura Y, Tsukaguchi H, et al. Factors associated with the development of sarcopenia in kidney transplant recipients. Transplant Proc. 2017;49(2):288-292. [CrossRef]
| APA | Gungor O, Duygu F, ULU M, Kalantar-Zadeh K (2022). Sarcopenia in Patients with Chronic Kidney Disease. , 3 - 6. 10.5152/turkjnephrol.2022.21223 |
| Chicago | Gungor Ozkan,Duygu Fatma betül,ULU MEMNUNE SENA,Kalantar-Zadeh Kamyar Sarcopenia in Patients with Chronic Kidney Disease. (2022): 3 - 6. 10.5152/turkjnephrol.2022.21223 |
| MLA | Gungor Ozkan,Duygu Fatma betül,ULU MEMNUNE SENA,Kalantar-Zadeh Kamyar Sarcopenia in Patients with Chronic Kidney Disease. , 2022, ss.3 - 6. 10.5152/turkjnephrol.2022.21223 |
| AMA | Gungor O,Duygu F,ULU M,Kalantar-Zadeh K Sarcopenia in Patients with Chronic Kidney Disease. . 2022; 3 - 6. 10.5152/turkjnephrol.2022.21223 |
| Vancouver | Gungor O,Duygu F,ULU M,Kalantar-Zadeh K Sarcopenia in Patients with Chronic Kidney Disease. . 2022; 3 - 6. 10.5152/turkjnephrol.2022.21223 |
| IEEE | Gungor O,Duygu F,ULU M,Kalantar-Zadeh K "Sarcopenia in Patients with Chronic Kidney Disease." , ss.3 - 6, 2022. 10.5152/turkjnephrol.2022.21223 |
| ISNAD | Gungor, Ozkan vd. "Sarcopenia in Patients with Chronic Kidney Disease". (2022), 3-6. https://doi.org/10.5152/turkjnephrol.2022.21223 |
| APA | Gungor O, Duygu F, ULU M, Kalantar-Zadeh K (2022). Sarcopenia in Patients with Chronic Kidney Disease. Turkish journal of nephrology (Online), 31(1), 3 - 6. 10.5152/turkjnephrol.2022.21223 |
| Chicago | Gungor Ozkan,Duygu Fatma betül,ULU MEMNUNE SENA,Kalantar-Zadeh Kamyar Sarcopenia in Patients with Chronic Kidney Disease. Turkish journal of nephrology (Online) 31, no.1 (2022): 3 - 6. 10.5152/turkjnephrol.2022.21223 |
| MLA | Gungor Ozkan,Duygu Fatma betül,ULU MEMNUNE SENA,Kalantar-Zadeh Kamyar Sarcopenia in Patients with Chronic Kidney Disease. Turkish journal of nephrology (Online), vol.31, no.1, 2022, ss.3 - 6. 10.5152/turkjnephrol.2022.21223 |
| AMA | Gungor O,Duygu F,ULU M,Kalantar-Zadeh K Sarcopenia in Patients with Chronic Kidney Disease. Turkish journal of nephrology (Online). 2022; 31(1): 3 - 6. 10.5152/turkjnephrol.2022.21223 |
| Vancouver | Gungor O,Duygu F,ULU M,Kalantar-Zadeh K Sarcopenia in Patients with Chronic Kidney Disease. Turkish journal of nephrology (Online). 2022; 31(1): 3 - 6. 10.5152/turkjnephrol.2022.21223 |
| IEEE | Gungor O,Duygu F,ULU M,Kalantar-Zadeh K "Sarcopenia in Patients with Chronic Kidney Disease." Turkish journal of nephrology (Online), 31, ss.3 - 6, 2022. 10.5152/turkjnephrol.2022.21223 |
| ISNAD | Gungor, Ozkan vd. "Sarcopenia in Patients with Chronic Kidney Disease". Turkish journal of nephrology (Online) 31/1 (2022), 3-6. https://doi.org/10.5152/turkjnephrol.2022.21223 |
